PNV - Banter and General Comments, page-9315

I think the encouraging thing was that Europe, the UK and Canada are reporting a big increase in sales over the past few months. That should enure the company hits the analyst target revenues for the FY, and hopefully give a good start to FY24. The initial Indian sales force are now trained and activated, but it will be a while before they start to get traction in the market.

The sales of a box of the large 40cm MTX to a US hospital is interesting. They must have a patient or perhaps a group of patients that they intend to use it on. That might be flap type surgery or maybe breast reconstruction or perhaps necrotising fasciitis. At some time in the future it might get published.

I think also that the loss from the launch in India and Capex for the new factory won't be very large since only a portion of the recent cap raise will be needed and it will be spread over several years while revenues continue to climb.

No doubt people will be critical of DWs rather long winded folksy style of presentation, but if you look past that, it's quite informative.